Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Knee Osteoarthritis With PAAG-OA

NCT: NCT04045431 · COMPLETED

NCT IDNCT04045431
StatusCOMPLETED
Start Date2019-05-15
Completion2025-03-10
SponsorContura (INDUSTRY)
First posted
Last updated

Brief Summary

This is a multi-center, randomized, double-blind clinical investigation to compare the effectiveness of intra-articular polyacrylamide hydrogel (PAAG-OA) and a hyaluronic acid, Synvisc-One to induce symptomatic benefit in subjects with knee osteoarthritis.

Frequently Asked Questions

What is Treatment of Knee Osteoarthritis With PAAG-OA?

Treatment of Knee Osteoarthritis With PAAG-OA is a clinical trial registered under NCT04045431. Current status: COMPLETED.

What is the status of NCT04045431?

The current status of NCT04045431 (Treatment of Knee Osteoarthritis With PAAG-OA) is: COMPLETED.

When did Treatment of Knee Osteoarthritis With PAAG-OA start?

Treatment of Knee Osteoarthritis With PAAG-OA started on 2019-05-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑